Altered thiol chemistry in human amyotrophic lateral sclerosis-linked mutants of superoxide dismutase 1

dc.contributor.authorSolsona Sancho, Carles
dc.contributor.authorKahn, Thomas B.
dc.contributor.authorBadilla, Carmen L.
dc.contributor.authorÁlvarez Zaldiernas, Cristina
dc.contributor.authorBlasi Cabús, Joan
dc.contributor.authorFernández, Julio M.
dc.contributor.authorAlegre-Cebollada, Jorge
dc.date.accessioned2021-04-27T13:26:05Z
dc.date.available2021-04-27T13:26:05Z
dc.date.issued2014-09-26
dc.date.updated2021-04-27T13:26:05Z
dc.description.abstractNeurodegenerative diseases share a common characteristic, the presence of intracellular or extracellular deposits of protein aggregates in nervous tissues. Amyotrophic Lateral Sclerosis (ALS) is a severe and fatal neurodegenerative disorder, which affects preferentially motoneurons. Changes in the redox state of superoxide dismutase 1 (SOD1) are associated with the onset and development of familial forms of ALS. In human SOD1 (hSOD1), a conserved disulfide bond and two free cysteine residues can engage in anomalous thiol/disulfide exchange resulting in non-native disulfides, a hallmark of ALS that is related to protein misfolding and aggregation. Because of the many competing reaction pathways, traditional bulk techniques fall short at quantifying individual thiol/disulfide exchange reactions. Here, we adapt recently developed single-bond chemistry techniques to study individual disulfide isomerization reactions in hSOD1. Mechanical unfolding of hSOD1 leads to the formation of a polypeptide loop held by the disulfide. This loop behaves as a molecular jump rope that brings reactive Cys-111 close to the disulfide. Using force-clamp spectroscopy, we monitor nucleophilic attack of Cys-111 at either sulfur of the disulfide and determine the selectivity of the reaction. Disease-causing mutations G93A and A4V show greatly altered reactivity patterns, which may contribute to the progression of familial ALS.
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec672852
dc.identifier.issn0021-9258
dc.identifier.pmid25096579
dc.identifier.urihttps://hdl.handle.net/2445/176729
dc.language.isoeng
dc.publisherAmerican Society for Biochemistry and Molecular Biology
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1074/jbc.M114.565333
dc.relation.ispartofJournal of Biological Chemistry, 2014, vol. 289, num. 39, p. 26722-26732
dc.relation.urihttps://doi.org/10.1074/jbc.M114.565333
dc.rights(c) American Society for Biochemistry and Molecular Biology, 2014
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationEsclerosi lateral amiotròfica
dc.subject.classificationEnzimologia
dc.subject.classificationCisteïna
dc.subject.classificationQuímica
dc.subject.otherAmyotrophic lateral sclerosis
dc.subject.otherEnzymology
dc.subject.otherCysteine
dc.subject.otherChemistry
dc.titleAltered thiol chemistry in human amyotrophic lateral sclerosis-linked mutants of superoxide dismutase 1
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
672852.pdf
Mida:
1.45 MB
Format:
Adobe Portable Document Format